- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Idiopathic inflammatory myopathy increases risk of CV events
UK: Idiopathic inflammatory myopathy (IIM) patients are at an increased risk of cardiovascular (CV) events similar to those found in rheumatoid arthritis (RA) with a greater excess risk during the first 5 years following the diagnosis, finds a recent study.
The study, published in the journal Clinical Rheumatology, calls for the development of guidelines on the assessment and management in IIM to take into account cardiovascular risk in IIM. This would help in reducing otherwise high mortality in IIM patients despite immunosuppressive treatment, with cardiac disease being a major cause of death.
Several connective tissue diseases and chronic inflammatory disorders are known to increase cardiovascular disease (CVD) risk secondary to accelerated atherosclerosis. Traditional risk factors for atherosclerotic vascular disease do not fully explain this increased CVD risk. Chronic systemic inflammation is thought to play an important role in accelerating the atherosclerotic processes.
Cristina Párraga Prieto, Centre for Rheumatic Diseases, King's College London, London, UK, and colleagues estimate the incidence of CV events in IIM compared to patients with RA and the general population. To explore the contribution of traditional CV risk factors to any difference observed.
The researchers conducted a retrospective matched population-based cohort study using UK Clinical Practice Research Datalink (CPRD) from 1987 to 2013. The incidence of CV events was calculated for each cohort over time and compared using Cox proportional hazards models. A total of 603 patients with IIM 4047 RA and 4061 healthy controls were included.
Key findings of the study include:
- The rate of CV events in IIM was significantly greater than healthy controls [hazard ratio (HR) 1.47] and remained significant after adjustment for CV risk factors [HR 1.38].
- Risk was similar between IIM and RA [HR 1.01].
- The rate of myocardial infarction [HR 1.61] but not stroke [HR 0.92] was significantly greater in IIM compared to healthy controls.
- After the first 5 years, the rate of CV events for RA remained significantly greater compared to the control group, but appeared to return to that of the healthy controls in the IIM group.
"IIM is associated with an increased risk of CV events in the first 5 years after diagnosis similar to that of RA. Beyond 5 years, the risk appears to return to that of the general population in IIM but not RA," concluded the authors.
The study, "Similar risk of cardiovascular events in idiopathic inflammatory myopathy and rheumatoid arthritis in the first 5 years after diagnosis," is published in the journal Clinical Rheumatology.
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751